Also known as amyloid beta 42, β-amyloid (1-42), and Aβ42.
PrevenTRON Phase III enrollment has started; Phase II TARBELA-AD launched for oral NLRP3 inhibitor RG6434; Brainshuttle trontinemab shows rapid amyloid removal; new Elecsys pTau217/pTau181 data published.
